Highest Score

Ranked by analysis score
Ranks this page's recent reports by score.
Alliance Laundry Holdings Inc.
ALH·Industrials
B ★★★Hold
Current$25.47
Target$30.00
Return+17.8%
Aug 20, 2026

Alliance Laundry Holdings dominates the commercial laundry equipment sector with highly sticky revenue and aggressive deleveraging, though valuation multiples and a significant private equity overhang warrant a balanced holding pattern.

Score
78
ICU Medical, Inc.
ICUI·Healthcare
B ★★★Hold
Current$182.98
Target$198.00
Return+8.2%
Aug 20, 2026

ICU Medical offers a deeply discounted, highly cash-generative turnaround play as it finalizes the Smiths Medical integration, though investors must remain vigilant regarding persistent tariff headwinds and aggressive insider equity sales.

Score
78
Century Aluminum Company
CENX·Materials
B ★★★Hold
Current$45.66
Target$70.50
Return+54.4%
Aug 19, 2026

Century Aluminum is a uniquely protected, cash-rich tollbooth leveraging U.S. tariffs and Icelandic renewable energy to print peak-cycle profits, though investors must remain hyper-vigilant regarding its total dependence on government subsidies and the looming, multi-billion-dollar execution risk of its unproven Oklahoma mega-smelter.

Score
78
Core Natural Resources, Inc.
CNR·Energy
B ★★★Hold
Current$95.94
Target$115.00
Return+19.9%
Aug 19, 2026

Core Natural Resources is an unrivaled cash-harvesting machine aggressively cannibalizing its own share count, yet it requires disciplined entry sizing due to the inescapable terminal decline of its thermal coal customer base and severe operational tail-risks.

Score
78
Dianthus Therapeutics, Inc.
DNTH·Healthcare
B ★★★Hold
Current$116.00
Target$138.00
Return+19.0%
Aug 18, 2026

Dianthus is a masterfully capitalized, best-in-class biotech poised to disrupt the multi-billion dollar autoimmune market with highly selective, convenient complement inhibitors, though its parabolic valuation demands flawless execution in upcoming late-stage clinical readouts.

Score
78
CRISPR Therapeutics AG
CRSP·Healthcare
B ★★★Hold
Current$54.28
Target$77.00
Return+41.8%
Aug 18, 2026

CRISPR Therapeutics commands a pristine, multi-billion-dollar balance sheet and the first-mover commercial monopoly in curative gene editing, though investors must exercise patience as the complex ex vivo manufacturing bottlenecks temporarily throttle near-term revenue velocity.

Score
78
California Resources Corporation
CRC·Energy
B ★★★Hold
Current$53.31
Target$63.55
Return+19.2%
Aug 18, 2026

California Resources presents a compelling free cash flow generation profile anchored by low-decline assets and transformational M&A, yet regulatory headwinds and cyclical commodity exposure demand a disciplined entry.

Score
78
RadNet, Inc.
RDNT·Healthcare
B ★★★Hold
Current$76.34
Target$84.50
Return+10.7%
Aug 18, 2026

RadNet offers a masterful, cash-gushing infrastructure monopoly supercharged by an explosive AI software subsidiary, but its historically extreme valuation dictates that investors wait for a structural pullback or consolidation before initiating a position.

Score
78
Golar LNG Limited
GLNG·Energy
B ★★★Hold
Current$52.49
Target$66.00
Return+25.7%
Aug 17, 2026

Golar LNG is the undisputed, monopolistic king of offshore liquefaction infrastructure, fortified by a staggering $17 billion contracted backlog, though investors must vigilantly navigate the execution risks of its heavy, multi-billion-dollar shipbuilding cycle.

Score
78
Klaviyo, Inc.
KVYO·Technology
B ★★★Hold
Current$18.49
Target$26.31
Return+42.3%
Aug 17, 2026

Klaviyo boasts a highly efficient, Rule of 40-clearing marketing automation platform with deep e-commerce roots, though investors must weigh its impressive cash generation against structural growth deceleration, SMS margin pressures, and heavy insider selling.

Score
78
Blackstone Secured Lending Fund
BXSL·Financials
B ★★★Hold
Current$25.01
Target$26.04
Return+4.1%
Aug 16, 2026

Blackstone Secured Lending is a best-in-class, ultra-defensive credit fortress offering a massive 12.3% yield anchored by a 97% first-lien portfolio, though investors must remain hyper-vigilant regarding near-term dividend sustainability as falling base rates relentlessly compress net investment income.

Score
78
Black Hills Corporation
BKH·Utilities
B ★★★Hold
Current$74.29
Target$78.12
Return+5.2%
Aug 16, 2026

Black Hills is an elite, hyper-reliable dividend compounder currently transforming into a high-growth infrastructure play via massive hyperscaler data center demand, though investors must closely monitor the severe regulatory and financing risks attached to its pending NorthWestern Energy merger.

Score
78